Macrolide antibiotics in pregnancy are linked with birth defects, study suggests
BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m659 (Published 19 February 2020) Cite this as: BMJ 2020;368:m659Linked Research
Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK
- Elisabeth Mahase
- The BMJ
Children of mothers who took macrolide antibiotics during early pregnancy have shown an increased risk of major birth defects, particularly heart defects, than children of mothers who took penicillin, in a study published in The BMJ.1
Macrolide antibiotics (including erythromycin, clarithromycin, and azithromycin) are used to treat common bacterial infections and are considered alternatives for patients with penicillin allergy. Researchers from Great Ormond Street Institute of Child Health said that these antibiotics should be “used with caution during pregnancy and, if possible, feasible alternative antibiotics should be prescribed until further research is available.”
However, Pat O’Brien, vice president of the Royal College of Obstetricians and Gynaecologists, said …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.